- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapeutic landscape in mutational triple negative breast cancer ; volume:17 ; number:1 ; day:14 ; month:7 ; year:2018 ; pages:1-11 ; date:12.2018
Molecular cancer ; 17, Heft 1 (14.7.2018), 1-11, 12.2018
- Creator
-
Shi, Yaqin
- Contributor
-
Jin, Juan
Ji, Wenfei
Guan, Xiaoxiang
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0850-9
- URN
-
urn:nbn:de:101:1-2018091313112271300817
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shi, Yaqin
- Jin, Juan
- Ji, Wenfei
- Guan, Xiaoxiang
- SpringerLink (Online service)
Other Objects (12)
Mutational landscape of inflammatory breast cancer
Mutational landscape of HSP family on human breast cancer
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Mutational landscape differences between young-onset and older-onset breast cancer patients
Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing
The mutational landscape of the adult healthy parous and nulliparous human breast
The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome
Compartment-specific mutational landscape of clonal hematopoiesis
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Ceritinib is a novel triple negative breast cancer therapeutic agent
Recent advances in therapeutic strategies for triple-negative breast cancer
The mutational landscape of atypical chronic myeloid leukemia
Mutational landscape of inflammatory breast cancer
Mutational landscape of HSP family on human breast cancer
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Mutational landscape differences between young-onset and older-onset breast cancer patients
Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing
The mutational landscape of the adult healthy parous and nulliparous human breast
The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome
Compartment-specific mutational landscape of clonal hematopoiesis
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Ceritinib is a novel triple negative breast cancer therapeutic agent
Recent advances in therapeutic strategies for triple-negative breast cancer
The mutational landscape of atypical chronic myeloid leukemia
Mutational landscape of inflammatory breast cancer
Mutational landscape of HSP family on human breast cancer
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Mutational landscape differences between young-onset and older-onset breast cancer patients
Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing
The mutational landscape of the adult healthy parous and nulliparous human breast
The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome
Compartment-specific mutational landscape of clonal hematopoiesis
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Ceritinib is a novel triple negative breast cancer therapeutic agent
Recent advances in therapeutic strategies for triple-negative breast cancer